Mycoplasma pneumoniae incidence, phenotype, and severity in children and adolescents in Denmark before, during, and after the COVID-19 pandemic: a nationwide multicentre population-based cohort study

被引:13
作者
Dungu, Kia H. S. [1 ]
Holm, Mette [2 ]
Harding, Ulla [3 ]
Jensen, Lise H. [4 ,5 ]
Nielsen, Allan Bybeck [6 ]
Schmidt, Lisbeth S. [5 ,7 ]
Toustrup, Lise B. [2 ]
Hansen, Lotte H. [8 ]
Dahl, Kathrin W. [9 ]
Matthesen, Kirstine T. [10 ]
Nordholm, Anne C. [11 ]
Uldum, Soren [12 ]
Emborg, Hanne-Dorthe [11 ]
Rytter, Maren J. H. [5 ,13 ]
Nygaard, Ulrikka [1 ,5 ]
机构
[1] Copenhagen Univ Hosp, Rigshosp, Dept Paediat & Adolescent Med, Blegdamsvej 9, DK-2100 Copenhagen, Denmark
[2] Aarhus Univ Hosp, Dept Paediat & Adolescent Med, Aarhus, Denmark
[3] Hans Christian Andersen Childrens Hosp, Dept Paediat & Adolescent Med, Odense, Denmark
[4] Zealand Univ Hosp, Dept Paediat & Adolescent Med, Roskilde, Denmark
[5] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark
[6] Copenhagen Univ Hosp, Dept Paediat & Adolescent Med, Hvidovre, Denmark
[7] Herlev Univ Hosp, Dept Paediat & Adolescent Med, Herlev, Denmark
[8] Univ Hosp Southern Denmark, Dept Paediat, Aabenraa, Denmark
[9] Hillerod Univ Hosp, Dept Paediat & Adolescent Med, Hillerod, Denmark
[10] Aalborg Univ Hosp, Dept Paediat & Adolescent Med, Aalborg, Denmark
[11] Statens Serum Inst, Dept Infect Dis Epidemiol & Prevent, Copenhagen, Denmark
[12] Statens Serum Inst, Dept Bacteria Parasites & Fungi, Copenhagen, Denmark
[13] Slagelse Hosp, Dept Paediat & Adolescent Med, Slagelse, Denmark
来源
LANCET REGIONAL HEALTH-EUROPE | 2024年 / 47卷
关键词
Mycoplasma; Mycoplasma pneumoniae; COVID-19; Resurgence; Mycoplasma induced rash and mucositis; MIRM; Reactive infectious mucocutaneous eruptions; RIME; Mycositis; Corticosteroids; INDUCED RASH; INFECTIONS;
D O I
10.1016/j.lanepe.2024.101103
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Mycoplasma pneumoniae infections resurged globally in 2023-2024 after a three-year decline during the COVID-19 pandemic. We explored the incidence and severity of M pneumoniae infections in children and adolescents before, during, and after the pandemic. Methods This nationwide, population-based cohort study included all Danish children and adolescents aged 0-17 years with a positive M pneumoniae PCR test from May 1, 2016, to April 30, 2024. We obtained clinical details for patients hospitalised for 24 h or more. Risk ratios for infections, hospitalisations, and disease manifestations in 2023-2024 versus pre-COVID-19 seasons were calculated using Fisher's exact and Pearson's chi(2) tests. A season was defined from May 1 to April 30. Findings Among the Danish population of 1,152,000 children and adolescents, 14,241 with a positive PCR test for Mpneumoniae were included. In 2023-2024, children and adolescents with a positive PCR rose 2.9-fold (95% CI 2.8-3.1; p < 0.0001) compared to the pre-COVID-19 seasons, and hospitalisations rose 2.6-fold (95% CI 2.0-3.3; p < 0.0001). M pneumoniae-induced rash and mucositis increased 5.3-fold (95% CI 1.8-15.3; p = 0.00 07). In 2023-2024 compared to the pre-COVID-19 seasons, there was no difference in the proportion of hospitalisation (360 [4%] of 8165 versus 230 [4%] of 6009; p = 0.09), the median duration of hospital stay (3 days [IQR 2-5] versus 3 days [IQR 2-5]; p = 0.84), or paediatric intensive care unit admission (14 [4%] of 360 versus 9 [4%] of 230 p = 1.00). Interpretation In Denmark, M pneumoniae infections and hospitalisations increased three-fold in 2023-2024 compared with the pre-COVID-19 seasons, indicating an immunity debt caused by the decline in M pneumoniae during the COVID-19 pandemic. While the severity of M pneumoniae infections did not change in 2023-2024, the five-fold increase in M pneumoniae-induced rash and mucositis in children and adolescents highlights M pneumoniae as an important pathogen causing mucocutaneous eruptions.Copyright (c) 2024 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
引用
收藏
页数:12
相关论文
共 51 条
[1]   Neurological Complications of PCR-Proven M. pneumoniae Infections in Children: Prodromal Illness Duration May Reflect Pathogenetic Mechanism [J].
Al-Zaidy, Samiah A. ;
MacGregor, Daune ;
Mahant, Sanjay ;
Richardson, Susan E. ;
Bitnun, Ari .
CLINICAL INFECTIOUS DISEASES, 2015, 61 (07) :1092-1098
[2]  
[Anonymous], 2023, Communicable disease threats report
[3]  
[Anonymous], WHO statement on reported clusters of respiratory illness in children in northern China
[4]   Mycoplasma pneumoniae Infections in Childhood [J].
Atkinson, T. Prescott ;
Waites, Ken B. .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (01) :92-94
[5]  
BIOFIRE, respiratory 2.1 (RP 2.1) Panel
[6]  
BioGX, 2024, Mycoplasma pneumoniae, Legionella pneumophila, Chlamydia pneumoniae, Pneumocystis jirovecii open system reagents for BD MAXTM
[7]   Increased incidence of Mycoplasma pneumoniae infections and hospital admissions in the Netherlands, November to December 2023 [J].
Bolluyt, Dita C. ;
Euser, Sjoerd M. ;
Souverein, Dennis ;
van Rossum, Annemarie M. C. ;
Kalpoe, Jayant ;
van Westreenen, Mireille ;
Goeijenbier, Marco ;
Snijders, Dominic ;
Eggink, Dirk ;
Jongenotter, Femke ;
van Lelyveld, Steven F. L. ;
van Houten, Marlies A. .
EUROSURVEILLANCE, 2024, 29 (04)
[8]   Unintended impacts of COVID-19 on the epidemiology and burden of paediatric respiratory infections [J].
Burrell, Rebecca ;
Saravanos, Gemma ;
Britton, Philip N. .
PAEDIATRIC RESPIRATORY REVIEWS, 2025, 53 :3-13
[9]   Mycoplasma pneumoniae-induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: A systematic review [J].
Canavan, Theresa N. ;
Mathes, Erin F. ;
Frieden, Ilona ;
Shinkai, Kanade .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (02) :239-U265
[10]  
CDC, 2024, About Mycoplasma pneumoniae Infection. Mycoplasma pneumoniae infection